Thermo Fisher Scientific
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Thermo Fisher Scientific (TMO) Business News
Track Thermo Fisher Scientific in real time with a live news feed covering Thermo Fisher Scientific stock news, official press releases, company announcements, and an archive of historical Thermo Fisher Scientific news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Thermo Fisher Scientific's PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
TMO DCF Analysis: Intrinsic Value $472 vs Price $496
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Baillie Gifford & Co.
Dara Capital US Inc. Buys Shares of 1,677 Thermo Fisher Scientific Inc. $TMO
Brown Lisle Cummings Inc. Acquires 1,775 Shares of Thermo Fisher Scientific Inc. $TMO
Altfest L J & Co. Inc. Purchases 2,806 Shares of Thermo Fisher Scientific Inc. $TMO
Carnegie Investment Counsel Has $27.51 Million Position in Thermo Fisher Scientific Inc. $TMO
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
9:56 AM | Tuesday | Apr 14, 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read full article
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment ResearchFinding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Read full article
Thermo Fisher Scientific's PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities
Business WireWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance data-driven clinical development and evidence generation for biopharma sponsors. Through the agreement, Thermo Fisher's PPD™ clinical research business will gain enterprise-level access to HealthVerity's TaXOnomy® claims dataset, representing more than 270 million de-identified pa.
Read full article
TMO DCF Analysis: Intrinsic Value $472 vs Price $496
GuruFocusOn April 13, 2026, we delve into the DCF analysis for Thermo Fisher Scientific Inc (TMO), a company that has experienced a mixed price performance recently, wit
Read full article
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Baillie Gifford & Co.
Defense WorldBaillie Gifford and Co. lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 56.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 770,868 shares of the medical research company's stock after acquiring an additional 279,635 shares
Read full article
Dara Capital US Inc. Buys Shares of 1,677 Thermo Fisher Scientific Inc. $TMO
Defense WorldDara Capital US Inc. bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,677 shares of the medical research company's stock, valued at approximately $972,000. Thermo Fisher Scientific makes up 0.
9% of
Brown Lisle Cummings Inc. Acquires 1,775 Shares of Thermo Fisher Scientific Inc. $TMO
Defense WorldBrown Lisle Cummings Inc. increased its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 26.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,581 shares of the medical research company's stock after buying an additional 1,775 shares during the period.
Altfest L J & Co. Inc. Purchases 2,806 Shares of Thermo Fisher Scientific Inc. $TMO
Defense WorldAltfest L J and Co. Inc. increased its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 47.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
The firm owned 8,689 shares of the medical research company's stock after acquiring an
Carnegie Investment Counsel Has $27.51 Million Position in Thermo Fisher Scientific Inc. $TMO
Defense WorldCarnegie Investment Counsel lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 4.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 47,467 shares of the medical research company's stock after selling 2,178 shares during the period. Carnegie Investment
Read full article
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
Zacks Investment ResearchTMO teams up with PRECISE on a major proteomics study, expanding its role in large biobank projects and precision medicine initiatives.
Read full article
The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down
MarketBeatThe Iran conflict has given investors a reason to sell just about everything. The Dow is in correction territory.
Read full article